1. Matrix metalloproteinase 2 is associated with changes in steroid hormones in the sera and peritoneal fluid of patients with endometriosis
- Author
-
Huang, He-Feng, Hong, Li-Hua, Tan, Yi, and Sheng, Jian-Zhong
- Subjects
- *
METALLOPROTEINASES , *PROTEINASES , *INFERTILITY , *PATIENTS - Abstract
Objective: To determine matrix metalloproteinase 2 (MMP-2) levels in sera and peritoneal fluids of women with or without endometriosis-associated infertility and to determine whether MMP-2 had correlation with 17β-E2 and P in the sera and peritoneal fluids of the patients with endometriosis.Design: A case–control study.Setting: A women''s hospital in China.Patient(s): Forty patients with endometriosis-associated infertility undergoing laparoscopy and 18 women undergoing tubal ligation.Intervention(s): Sera and peritoneal fluids were collected from women with or without endometriosis.Main outcome measure(s): Matrix metalloproteinase 2, 17β-E2, and P concentration.Result(s): Compared with the control women, the patients with endometriosis had higher MMP-2 levels in their sera and peritoneal fluids. Serum and peritoneal fluid MMP-2 levels were higher in the proliferative phase than in the secretory phase. The level of MMP-2 in the patients was correlated positively with 17β-E2 in serum and peritoneal fluid and negatively with P.Conclusion(s): The results demonstrated a correlation between MMP-2 concentrations and steroid hormones in sera and peritoneal fluids of the patients with endometriosis-associated infertility. Estradiol might up-regulate MMP-2, resulting in the formation of endometriosis. Progesterone might down-regulate MMP-2 to inhibit the formation and development of endometriosis. [Copyright &y& Elsevier]
- Published
- 2004
- Full Text
- View/download PDF